Sandra Agnieszka Pilawska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sandra Agnieszka Pilawska has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Borys Maria Kwinta
Department of Neurosurgery and Neurotraumatology, Jagiellonian University Medical College, Krakow, Poland
4 shared publications - Ewa Katarzyna Malaka
The University Hospital in Krakow, Krakow, Poland
4 shared publications - Krzysztof Bilecki
SP ZOZ MSWiA, Kronikarza Galla 25, 30-053 Cracow, Poland
4 shared publications - Magdalena Muzyk
5th Military Clinical Hospital with Policlinic (SPZOZ) in Krakow, ul. Wrocławska 1-3, 30-901 Kraków, Poland
4 shared publications - Maria Maślankiewicz
The University Hospital in Krakow, Jakubowskiego 2 Street, 30-688 Krakow, Poland
4 shared publications - Michał Bado
The University Hospital in Krakow, Jakubowskiego 2 Street, 30-688 Krakow, Poland
4 shared publications
Latest Publications
- Open Access
- 24 September 2026
- Published by Springer Nature in Acta Neurochirurgica
Robotic versus frame-based stereotactic biopsy in the diagnostics of focal brain lesions: a retrospective comparative study
- 24 September 2026
- Published by Springer Nature in Acta Neurochirurgica
Open AccessRobotic versus frame-based stereotactic biopsy in the diagnostics of focal brain lesions: a retrospective comparative study
- Open Access
- 29 May 2025
- Published by Elsevier in World Neurosurgery
- Vol. 199, 124128
Facial Nerve Palsy as a Complication of Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: Report of 3 Cases and Review of Literature
- 29 May 2025
- Published by Elsevier in World Neurosurgery
- Vol. 199, 124128
Open AccessFacial Nerve Palsy as a Complication of Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: Report of 3 Cases and Review of Literature
- 21 February 2025
- Published by Springer Nature in Surgical and Radiologic Anatomy
- Vol. 47 (1) , 1-7
A typical course of v3 segment of the right vertebral artery: a case study and literature overview
Purpose To describe a case of atypical course of V3 segment of the right vertebral artery (VA) that runs through the hypoglossal canal. Methods A 60-year-old female was qualified as clinical control group to participate in a clinical trial and two imaging methods in High Field Magnetic Resonance Imaging (1.5T): 3D FFE TOF and 3D T1 MPRAGE were performed. Results In this case, the right VA enters the skull abnormally, through the hypoglossal canal. Research has shown that it is presumably a variant of persistent primitive hypoglossal artery (PPHA) or a partial persistence of the PPHA incorporated into the VA. Previous MRI images did not reveal any abnormalities in the structure in the vasculature of the brain, as well. Conclusion Proper recognition and analysis of vascular variations are critical to avoid iatrogenic complications or to plan surgery of head or neck regions. Secondly, such anatomic variation may predispose a patient to ischemic attacks due to insufficient blood flow or aneurysms due to a weakened wall or stenosis of the VA.
- 21 February 2025
- Published by Springer Nature in Surgical and Radiologic Anatomy
- Vol. 47 (1) , 1-7
A typical course of v3 segment of the right vertebral artery: a case study and literature overview
Purpose To describe a case of atypical course of V3 segment of the right vertebral artery (VA) that runs through the hypoglossal canal. Methods A 60-year-old female was qualified as clinical control group to participate in a clinical trial and two imaging methods in High Field Magnetic Resonance Imaging (1.5T): 3D FFE TOF and 3D T1 MPRAGE were performed. Results In this case, the right VA enters the skull abnormally, through the hypoglossal canal. Research has shown that it is presumably a variant of persistent primitive hypoglossal artery (PPHA) or a partial persistence of the PPHA incorporated into the VA. Previous MRI images did not reveal any abnormalities in the structure in the vasculature of the brain, as well. Conclusion Proper recognition and analysis of vascular variations are critical to avoid iatrogenic complications or to plan surgery of head or neck regions. Secondly, such anatomic variation may predispose a patient to ischemic attacks due to insufficient blood flow or aneurysms due to a weakened wall or stenosis of the VA.
- Open Access
- 23 October 2024
- Published by Elsevier in World Neurosurgery
- Vol. 192, e468-e473
Distribution of the Middle Meningeal Artery Variants in Patients Undergoing Embolization for Chronic Subdural Hematoma
- 23 October 2024
- Published by Elsevier in World Neurosurgery
- Vol. 192, e468-e473
Open AccessDistribution of the Middle Meningeal Artery Variants in Patients Undergoing Embolization for Chronic Subdural Hematoma
- Open Access
- 31 August 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 19, 54097
The role of supplementation in traumatic brain injury among athletes and non-athletes population
Introduction: Traumatic brain injury (TBI) is one of the most common causes of death and long-term disability. The consequences following TBI can be persistent and cause life-long implications for survivors. Treatment of TBI may be complex and involve large monetary costs. The frequent injury mechanisms are traffic-related, falls, violence or sport-related accidents. Higher risk of brain injury and its complications indicate that people affected by brain trauma may benefit from the prophylactic and post-traumatic use of certain supplements both in the context of physical performance and in the event of potential injury. Aim of the Study: This narrative review examines the current literature of the role of supplementation before and after TBI and its effects on the patient's outcome. Materials and Methods: A comprehensive search was performed using PubMed and Google Scholar focusing on the literature published up to April 2024. The review included randomized controlled trials, meta-analyses, systematic reviews that focused on the use of creatine monohydrate, omega-3 fatty acids, magnesium and zinc in TBI and among the general population. Data of pathophysiology and epidemiology of TBI and safety profile of supplements were involved. Results: The evidence indicates that the role of supplementation with creatine, omega-3 PUFAs and zinc is important in mitigating secondary damage after TBI, as well as in protecting against damage if administered before injury. Conclusion: Because of the complex and multifactorial nature of the TBI more studies are required to constitute an effective nutrition-based strategy for reducing the cognitive and behavioral deficits associated with this injury. The evidence supporting multiple dietary components to improve a patient's outcome seems strong and the cost of its implementation is low. A group of particular interest that may benefit additionally are athletes who use dietary supplementation in their daily routine.
- 31 August 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 19, 54097
Open AccessThe role of supplementation in traumatic brain injury among athletes and non-athletes population
Introduction: Traumatic brain injury (TBI) is one of the most common causes of death and long-term disability. The consequences following TBI can be persistent and cause life-long implications for survivors. Treatment of TBI may be complex and involve large monetary costs. The frequent injury mechanisms are traffic-related, falls, violence or sport-related accidents. Higher risk of brain injury and its complications indicate that people affected by brain trauma may benefit from the prophylactic and post-traumatic use of certain supplements both in the context of physical performance and in the event of potential injury. Aim of the Study: This narrative review examines the current literature of the role of supplementation before and after TBI and its effects on the patient's outcome. Materials and Methods: A comprehensive search was performed using PubMed and Google Scholar focusing on the literature published up to April 2024. The review included randomized controlled trials, meta-analyses, systematic reviews that focused on the use of creatine monohydrate, omega-3 fatty acids, magnesium and zinc in TBI and among the general population. Data of pathophysiology and epidemiology of TBI and safety profile of supplements were involved. Results: The evidence indicates that the role of supplementation with creatine, omega-3 PUFAs and zinc is important in mitigating secondary damage after TBI, as well as in protecting against damage if administered before injury. Conclusion: Because of the complex and multifactorial nature of the TBI more studies are required to constitute an effective nutrition-based strategy for reducing the cognitive and behavioral deficits associated with this injury. The evidence supporting multiple dietary components to improve a patient's outcome seems strong and the cost of its implementation is low. A group of particular interest that may benefit additionally are athletes who use dietary supplementation in their daily routine.
- Open Access
- 29 August 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 19, 53905
Impact of tango on Parkinson's disease - a narrative review
Introduction: Parkinson’s disease (PD) is a fast-growing neurodegenerative condition caused by the deficiency of dopamine (Bloem et al., 2021). Main symptoms include tremor, bradykinesia, muscular rigidity and postural instability (Ye et al., 2023). Although PD treatment primarily involves pharmacotherapy, physical activity-based treatments such as tango dance can improve the quality of life of patients. Aim of the study: This narrative review aims to assess the impact of the therapeutic benefits of tango dance therapy for people with PD. Materials and methods: A comprehensive literature search was conducted in the PubMed database up to 2024. The review included randomised controlled trials, case reports, and pilot studies focused on the impact of tango on PD. Results: Several studies have evaluated the impact of tango on patients with PD. Some of them found that tango improves dynamic balance and walking, reduces the risk of falling, improves body awareness, stability, and emotional well-being among patients with PD. Conclusions: The impact of tango on PD is not yet conclusively documented, and further research is needed.
- 29 August 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 19, 53905
Open AccessImpact of tango on Parkinson's disease - a narrative review
Introduction: Parkinson’s disease (PD) is a fast-growing neurodegenerative condition caused by the deficiency of dopamine (Bloem et al., 2021). Main symptoms include tremor, bradykinesia, muscular rigidity and postural instability (Ye et al., 2023). Although PD treatment primarily involves pharmacotherapy, physical activity-based treatments such as tango dance can improve the quality of life of patients. Aim of the study: This narrative review aims to assess the impact of the therapeutic benefits of tango dance therapy for people with PD. Materials and methods: A comprehensive literature search was conducted in the PubMed database up to 2024. The review included randomised controlled trials, case reports, and pilot studies focused on the impact of tango on PD. Results: Several studies have evaluated the impact of tango on patients with PD. Some of them found that tango improves dynamic balance and walking, reduces the risk of falling, improves body awareness, stability, and emotional well-being among patients with PD. Conclusions: The impact of tango on PD is not yet conclusively documented, and further research is needed.
- Open Access
- 22 August 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 20, 53988
Effectiveness of kiwi fruit in treating constipation - narrative review
Introduction: Constipation is a widespread digestive issue characterized by infrequent bowel movements and difficulty in passing stools. While conventional treatments include dietary fiber, laxatives, and lifestyle changes, recent studies have suggested that kiwifruit may offer a natural and effective alternative. This narrative review evaluates the efficacy of kiwifruit in managing and alleviating symptoms of constipation. Aim of the study: The primary aim of this study is to synthesize existing research on the effectiveness of kiwifruit in treating constipation. By examining various clinical trials and observational studies, the review aims to elucidate the therapeutic benefits and mechanisms of action of kiwifruit in improving bowel function. Materials and Methods: A comprehensive literature search was performed using databases such as PubMed, Scopus, and Google Scholar. Data were extracted and analyzed regarding the frequency of bowel movements, stool consistency, and overall gastrointestinal health following kiwifruit consumption. Results: The review identified that regular consumption of kiwifruit significantly enhances bowel function in both constipated and non-constipated individuals. Clinical trials consistently report increased stool frequency, softer stool consistency, and reduced colonic transit time. The beneficial effects are attributed to the high fiber content of kiwifruit and the presence of the enzyme actinidin, which promotes digestion and bowel movements. Kiwifruit was found to be well-tolerated with minimal adverse effects. Conclusion:Kiwifruit appears to be a promising natural remedy for constipation, providing substantial improvements in bowel movement regularity and stool characteristics. Its high fiber content and unique enzymatic properties contribute to its effectiveness. Further research is recommended to explore the long-term benefits and potential applications of different varieties of kiwifruit in diverse patient populations.
- 22 August 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 20, 53988
Open AccessEffectiveness of kiwi fruit in treating constipation - narrative review
Introduction: Constipation is a widespread digestive issue characterized by infrequent bowel movements and difficulty in passing stools. While conventional treatments include dietary fiber, laxatives, and lifestyle changes, recent studies have suggested that kiwifruit may offer a natural and effective alternative. This narrative review evaluates the efficacy of kiwifruit in managing and alleviating symptoms of constipation. Aim of the study: The primary aim of this study is to synthesize existing research on the effectiveness of kiwifruit in treating constipation. By examining various clinical trials and observational studies, the review aims to elucidate the therapeutic benefits and mechanisms of action of kiwifruit in improving bowel function. Materials and Methods: A comprehensive literature search was performed using databases such as PubMed, Scopus, and Google Scholar. Data were extracted and analyzed regarding the frequency of bowel movements, stool consistency, and overall gastrointestinal health following kiwifruit consumption. Results: The review identified that regular consumption of kiwifruit significantly enhances bowel function in both constipated and non-constipated individuals. Clinical trials consistently report increased stool frequency, softer stool consistency, and reduced colonic transit time. The beneficial effects are attributed to the high fiber content of kiwifruit and the presence of the enzyme actinidin, which promotes digestion and bowel movements. Kiwifruit was found to be well-tolerated with minimal adverse effects. Conclusion:Kiwifruit appears to be a promising natural remedy for constipation, providing substantial improvements in bowel movement regularity and stool characteristics. Its high fiber content and unique enzymatic properties contribute to its effectiveness. Further research is recommended to explore the long-term benefits and potential applications of different varieties of kiwifruit in diverse patient populations.
- Open Access
- 19 August 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 19, 53789
Liquid Levothyroxine: Efficacy and Application in the Treatment of Myxoedema Coma - A Narrative Review
Introduction: Myxoedema coma is a severe and rare manifestation of hypothyroidism that requires immediate and effective intervention. Traditional treatment involves the use of levothyroxine, a synthetic thyroid hormone. Liquid levothyroxine presents an alternative formulation that may offer advantages in the critical care setting, particularly when gastrointestinal absorption is impaired. Aim of the Study: This narrative review aims to evaluate the efficacy and application of liquid levothyroxine in the treatment of myxoedema coma, comparing it to other available forms and providing insights into its clinical use. Materials and Methods: A comprehensive literature search was conducted using databases such as PubMed, Medline, and Cochrane Library. Studies, clinical trials, case reports, and reviews were included if they addressed the use of liquid levothyroxine in myxoedema coma. Data were extracted and analyzed to assess the pharmacokinetics, administration protocols, outcomes, and comparative efficacy of liquid levothyroxine. Results: The review identified several key studies and case reports indicating that liquid levothyroxine offers superior bioavailability and faster onset of action compared to oral tablets, particularly in patients with compromised gastrointestinal function. Case studies demonstrated improved clinical outcomes and recovery times with liquid levothyroxine, highlighting its potential benefits in the acute management of myxoedema coma. Conclusion: Liquid levothyroxine appears to be a promising alternative for the treatment of myxoedema coma, offering enhanced absorption and rapid therapeutic effects. While preliminary data are encouraging, further research and clinical trials are necessary to establish standardized treatment protocols and confirm its efficacy. Understanding the role of liquid levothyroxine in this critical condition can enhance treatment strategies and improve patient outcomes.
- 19 August 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 19, 53789
Open AccessLiquid Levothyroxine: Efficacy and Application in the Treatment of Myxoedema Coma - A Narrative Review
Introduction: Myxoedema coma is a severe and rare manifestation of hypothyroidism that requires immediate and effective intervention. Traditional treatment involves the use of levothyroxine, a synthetic thyroid hormone. Liquid levothyroxine presents an alternative formulation that may offer advantages in the critical care setting, particularly when gastrointestinal absorption is impaired. Aim of the Study: This narrative review aims to evaluate the efficacy and application of liquid levothyroxine in the treatment of myxoedema coma, comparing it to other available forms and providing insights into its clinical use. Materials and Methods: A comprehensive literature search was conducted using databases such as PubMed, Medline, and Cochrane Library. Studies, clinical trials, case reports, and reviews were included if they addressed the use of liquid levothyroxine in myxoedema coma. Data were extracted and analyzed to assess the pharmacokinetics, administration protocols, outcomes, and comparative efficacy of liquid levothyroxine. Results: The review identified several key studies and case reports indicating that liquid levothyroxine offers superior bioavailability and faster onset of action compared to oral tablets, particularly in patients with compromised gastrointestinal function. Case studies demonstrated improved clinical outcomes and recovery times with liquid levothyroxine, highlighting its potential benefits in the acute management of myxoedema coma. Conclusion: Liquid levothyroxine appears to be a promising alternative for the treatment of myxoedema coma, offering enhanced absorption and rapid therapeutic effects. While preliminary data are encouraging, further research and clinical trials are necessary to establish standardized treatment protocols and confirm its efficacy. Understanding the role of liquid levothyroxine in this critical condition can enhance treatment strategies and improve patient outcomes.